OKAH ANYOKWU: Open Payments
NPI 1720242720 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,862 in 120 payments from 20 companies in 2025. Trend: 2023 $2,274 · 2024 $2,065 · 2025 $1,862
Food & beverage: $1,862
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 24 | $289 |
| E.R. Squibb & Sons, L.L.C. | 9 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $187 |
| Axsome Therapeutics, Inc. | 8 | $167 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $166 |
| ABBVIE INC. | 14 | $155 |
| Collegium Pharmaceutical, Inc. | 11 | $144 |
| Otsuka America Pharmaceutical, Inc. | 9 | $142 |
| Alkermes, Inc. | 4 | $83 |
| Janssen Pharmaceuticals, Inc | 4 | $77 |
Products named: COBENFY, CAPLYTA, Auvelity, TRINTELLIX, VRAYLAR, UZEDY, Jornay PM, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
